22 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorderdepressive disorder, major depressive disorder, mood disorder, psychiatric disorderRecruitingPhase 32026-10-05NCT06793397
Pramipexole to Enhance Social Connectionsanxiety, anxiety disorder, depressive disorder, psychiatric disorderActive, not recruitingPhase 22026-09-23NCT06269146
DecNef for AVH in SchizophreniaHallucinations, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Schizophrenia Spectrum and Other Psychotic Disorders, Signs and Symptoms, nervous system disorder, perceptual disorders, psychiatric disorder, schizophreniaNot yet recruitingPhase 1 / Phase 22026-09-15NCT07779226
Broadband Near Infrared Spectroscopy to Understand the Role of Brain Cytochrome C Oxidase in Bipolar DisorderBipolar and Related Disorders, bipolar disorder, depressive disorder, mood disorder, psychiatric disorderNot yet recruitingPhase 42026-09-08NCT07806227
Olfactory Training in Mild Cognitive ImpairmentCognition Disorders, Cognitive Dysfunction, Memory Disorders, Mild Cognitive Impairment, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, anosmia, cognitive disorder, nervous system disorder, psychiatric disorderRecruitingNot applicable2026-09-04NCT06825403
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRDDepressive Disorder, Treatment-Resistant, depressive disorder, mood disorder, psychiatric disorderActive, not recruitingPhase 32026-08-10NCT05711940
Air Pollution and Development in the Boricua Youth Studyneurodevelopmental disorder, psychiatric disorderEnrolling by invitationNot applicable2026-08-06NCT05368493
Understanding the Role of the Kappa Opioid Receptor in Ketamine's Attenuation of Suicidal Thoughtsdepressive disorder, major depressive disorder, mood disorder, psychiatric disorderNot yet recruitingPhase 42026-08-03NCT07139106
An Open Trial of a Novel Pharmacotherapy for Habit Modification in Anorexia NervosaAnorexia, Feeding and Eating Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, anorexia nervosa, psychiatric disorderNot yet recruitingPhase 22026-08-03NCT06518941
Sleep Interventions and Neurocognitive OutcomesAlzheimer disease, Parasomnias, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, sleep disorder, sleep-wake disorder, tauopathyNot yet recruitingNot applicable2026-08-03NCT05987007
Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic MedicationsNegative Symptoms of SchizophreniaRecruitingPhase 32026-07-28NCT07565428
How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCDobsessive-compulsive personality disorderRecruitingNot applicable2026-07-22NCT05359562
Effects of rTMS on Food Choice in Anorexia NervosaFeeding and Eating Disorders, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, anorexia nervosa, psychiatric disorderRecruitingNot applicable2026-07-15NCT05918835
A PET/MRI Study of Cobenfy on Dopamine Transmission in SchizophreniaSCHIZOPHRENIA 1 (Disorder); Schizoaffecitve DisorderRecruitingPhase 1 / Phase 22026-07-14NCT07423546
Exercise and Olanzapine-samidorphanBipolar and Related Disorders, Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, bipolar disorder, mood disorder, psychiatric disorder, schizoaffective disorderRecruitingPhase 42026-07-13NCT06740890
Facilitating Opioid Care ConnectionsMedication to Treat Opioid Use Disorder; Opioid Court Model; Opioid UseActive, not recruitingNot applicable2026-06-30NCT04216719
Relapse Prevention and Changing Habits in Anorexia NervosaFeeding and Eating Disorders, anorexia nervosa, psychiatric disorderRecruitingNot applicable2026-06-01NCT04810624
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical TrialPsychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorder, schizoaffective disorder, schizophreniaRecruitingPhase 42026-05-04NCT05208190
Impacts of Cash Transfers on Child Neurodevelopment (Auxilio Brasil)Inflammation, Pathologic Processes, Pathological Conditions, Signs and SymptomsRecruitingNot applicable2026-04-23NCT05477901
Sublingual Dexmedetomidine for Treating Opioid WithdrawalChemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorderActive, not recruitingPhase 1 / Phase 22026-04-14NCT05712707
Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Sequelae of COVID (PASC): A Pilot TrialCOVID-19, Chronic Disease, Cognition Disorders, Cognitive Dysfunction, Coronaviridae Infections, Disease Attributes, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, cognitive disorder, depressive disorder, long COVID-19, lung disorder, pneumonia, psychiatric disorder, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumoniaActive, not recruitingPhase 22024-07-16NCT05690503
Facilitating Rapid Naltrexone InitiationChemically-Induced Disorders, Narcotic-Related Disorders, opiate dependence, psychiatric disorder, substance-related disorderActive, not recruitingPhase 32024-02-02NCT03345173